Why we need more collaboration in Europe to enhance post-marketing surveillance of vaccines-Reference-Cited by-同舟云学术

Why we need more collaboration in Europe to enhance post-marketing surveillance of vaccines

Published:2020-12 Issue: Volume:38 Page:B1-B7
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Sturkenboom Miriam^ORCID,Bahri Priya,Chiucchiuini Antonella,Grove Krause Tyra,Hahné Susan,Khromava Alena,Kokki Maarit,Kramarz Piotr,Kurz Xavier,Larson Heidi J.,de Lusignan Simon,Mahy Patrick,Torcel-Pagnon Laurence,Titievsky Lina,Bauchau Vincent

Funder

MediCom Consult

Novartis

Innovative Medicines Initiative

European Union's Seventh Framework Programme

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference38 articles.

1. Chapter 1: a short history of vaccination;Plotkin,2018

2. World Health Organisation. Vaccine safety basics - elearning course. Module 1: History of vaccine development 2018 [Last accessed 15 May 2018]. Available from: http://vaccine-safety-training.org/history-of-vaccine-development.html.

3. World Health Organisation. Vaccines and diseases 2018 [Last accessed 15 May 2018]. Available from: http://www.who.int/immunization/diseases/en/.

4. Global immunization: status, progress, challenges and future;Duclos;BMC Int Health Human Rights,2009

5. Vaccination greatly reduces disease, disability, death and inequity worldwide;Andre;Bull World Health Organ,2008

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sequence Labelling with 2 Level Segregation (SL2LS): A framework to extract COVID-19 vaccine adverse drug reactions from Twitter data;Expert Systems with Applications;2024-09

2. Worldwide network initiatives in improving pediatric drug research;Essentials of Translational Pediatric Drug Development;2024

3. Regulatory processes involved in clinical trials and intellectual property rights around vaccine development;Advanced Vaccination Technologies for Infectious and Chronic Diseases;2024

4. Effectiveness and safety of recombinant zoster vaccine: A review of real-world evidence;Human Vaccines & Immunotherapeutics;2023-11-15

5. Three seasons of enhanced safety surveillance of a cell culture-based quadrivalent influenza vaccine;Human Vaccines & Immunotherapeutics;2023-08